Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity von Lampson, Benjamin L., Kasar, Siddha N., Matos, Tiago R., Morgan, Elizabeth A., Rassenti, Laura, Davids, Matthew S., Fisher, David C., Freedman, Arnold S., Jacobson, Caron A., Armand, Philippe, Abramson, Jeremy S., Arnason, Jon E., Kipps, Thomas J., Fein, Joshua, Fernandes, Stacey, Hanna, John, Ritz, Jerome, Kim, Haesook T., Brown, Jennifer R.

Volltext

Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study von Abramson, Jeremy S., Solomon, Scott R., Arnason, Jon, Johnston, Patrick B., Glass, Bertram, Bachanova, Veronika, Ibrahimi, Sami, Mielke, Stephan, Mutsaers, Pim, Hernandez-Ilizaliturri, Francisco, Izutsu, Koji, Morschhauser, Franck, Lunning, Matthew, Crotta, Alessandro, Montheard, Sandrine, Previtali, Alessandro, Ogasawara, Ken, Kamdar, Manali

Volltext

Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study von Davids, Matthew S, Lampson, Benjamin L, Tyekucheva, Svitlana, Wang, Zixu, Lowney, Jessica C, Pazienza, Samantha, Montegaard, Josie, Patterson, Victoria, Weinstock, Matthew, Crombie, Jennifer L, Ng, Samuel Y, Kim, Austin I, Jacobson, Caron A, LaCasce, Ann S, Armand, Philippe, Arnason, Jon E, Fisher, David C, Brown, Jennifer R

Volltext

Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort i... von Bannerji, Rajat, Arnason, Jon E, Advani, Ranjana H, Brown, Jennifer R, Allan, John N, Ansell, Stephen M, Barnes, Jeffrey A, O'Brien, Susan M, Chávez, Julio C, Duell, Johannes, Rosenwald, Andreas, Crombie, Jennifer L, Ufkin, Melanie, Li, Jingjin, Zhu, Min, Ambati, Srikanth R, Chaudhry, Aafia, Lowy, Israel, Topp, Max S

Volltext

Tumor-Targeted Human T Cells Expressing CD28-Based Chimeric Antigen Receptors Circumvent CTLA-4 Inhibition von Condomines, Maud, Arnason, Jon, Benjamin, Reuben, Gunset, Gertrude, Plotkin, Jason, Sadelain, Michel

Volltext

Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphoma von Abramson, Jeremy S., Arnason, Jon E., LaCasce, Ann S., Redd, Robert, Barnes, Jeffrey A., Sokol, Lubomir, Joyce, Robin, Avigan, David, Neuberg, Donna, Takvorian, Ronald W., Hochberg, Ephraim P., Bello, Celeste M.

Volltext

High CD34‐positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft‐versus‐host disease or mortality von Avigan, Zachary M., Dias, Ajoy L., Dodge, Laura E., Arnason, Jon E., Joyce, Robin M., Liegel, Jessica, Rosenblatt, Jacalyn, Weinstock, Matthew J., Avigan, David E., Haspel, Richard L.

Volltext

Umbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1–1b study von Davids, Matthew S, Kim, Haesook T, Nicotra, Alyssa, Savell, Alexandra, Francoeur, Karen, Hellman, Jeffrey M, Bazemore, Josie, Miskin, Hari P, Sportelli, Peter, Stampleman, Laura, Maegawa, Rodrigo, Rueter, Jens, Boruchov, Adam M, Arnason, Jon E, Jacobson, Caron A, Jacobsen, Eric D, Fisher, David C, Brown, Jennifer R

Volltext

Real-World Treatment Patterns After CD19-Directed CAR T Cell Therapy Among Patients with Diffuse Large B Cell Lymphoma von Jalbert, Jessica J., Wu, Ning, Chen, Chieh-I, Ambati, Srikanth, Ge, Wenzhen, Arnason, Jon E.

Volltext

Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-In... von Hasan, Haytham, Surjancev, Ivana, Arnason, Jon A., Garg, Shivani, Rose, William Nicholas

Volltext

Targeting B Cell Signaling in Chronic Lymphocytic Leukemia von Arnason, Jon E., Brown, Jennifer R.

Volltext

Targeted Therapy for Chronic Lymphocytic Leukemia: Current Status and Future Directions von Arnason, Jon E., Brown, Jennifer R.

Volltext

Correlation between patient recall of bone densitometry results and subsequent treatment adherence von PICKNEY, Cynthia S, ARNASON, Jon A

Volltext

The effect of oxygen saturation on the growth and feed conversion of juvenile Atlantic cod (Gadus morhua L.) von Thorarensen, Helgi, Gústavsson, Arnþór, Gunnarsson, Snorri, Árnason, Jón, Steinarsson, Agnar, Björnsdóttir, Rannveig, Imsland, Albert K.D.

Volltext

Effect of rearing temperature on flesh quality in Arctic charr (Salvelinus alpinus) von Imsland, Albert K. D., Ólafsdóttir, Aðalheiður, Árnason, Jón, Gústavsson, Arnþór, Thorarensen, Helgi, Gunnarsson, Snorri

Volltext

Abnormalities in IgA and IgM are associated with treatment-resistant ITP von Arnason, Jon E., Campigotto, Federico, Neuberg, Donna, Bussel, James B.

Volltext

Dietary lipid oxidation tolerance of juvenile Arctic charr (Salvelinus alpinus) and Nile tilapia (Oreochromis niloticus) von Kubiriza, Godfrey Kawooya, Árnason, Jón, Sigurgeirsson, Ólafur, Hamaguchi, Patricia, Snorrason, Sigurdur, Tómasson, Tumi, Thorarensen, Helgi

Volltext

Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia von Lampson, Benjamin L., Kim, Haesook T., Davids, Matthew S., Abramson, Jeremy S., Freedman, Arnold S., Jacobson, Caron A., Armand, Philippe A., Joyce, Robin M., Arnason, Jon E., Rassenti, Laura Z., Kipps, Thomas J., Fein, Joshua, Fernandes, Stacey M., Hanna, John R., Fisher, David C., Brown, Jennifer R.

Volltext

Lenalidomide enhances anti-myeloma cellular immunity von Luptakova, Katarina, Rosenblatt, Jacalyn, Glotzbecker, Brett, Mills, Heidi, Stroopinsky, Dina, Kufe, Turner, Vasir, Baldev, Arnason, Jon, Tzachanis, Dimitri, Zwicker, Jeffrey I., Joyce, Robin M., Levine, James D., Anderson, Kenneth C., Kufe, Donald, Avigan, David

Volltext

Alemtuzumab use in relapsed and refractory chronic lymphocytic leukemia: a history and discussion of future rational use von Warner, Jeremy L., Arnason, Jon E.

Volltext